Selective and Potent Inhibitory Effect of Docosahexaenoic Acid (DHA) on U46619-induced Contraction in Rat Aorta

Overview

Journal J Smooth Muscle Res

Specialty Physiology

Date 2013 Dec 6

PMID 24304639

Citations 8

Authors

Kyosuke Sato

Daisuke Chino

Tomoya Kobayashi

Keisuke Obara

Seiji Miyauchi

Yoshio Tanaka

Affiliations

Soon will be listed here.

Abstract

Inhibitory effects of docosahexaenoic acid (DHA) on blood vessel contractions induced by various constrictor stimulants were investigated in the rat thoracic aorta. The inhibitory effects of DHA were also compared with those of eicosapentaenoic acid (EPA) and linoleic acid (LA). DHA exhibited a strong inhibitory effect on the sustained contractions induced by U46619, a TXA(2) mimetic. This inhibitory effect of DHA was not affected by removal of the endothelium or by treatment with either indomethacin or N(ω)-nitro-l-arginine. DHA also significantly diminished PGF(2α)-induced contraction but did not show any appreciable inhibitory effects on the contractions to both phenylephrine (PE) and high-KCl. Similarly, EPA exhibited significant inhibitory effects against the contractions induced by both U46619 and PGF(2α) without substantially affecting either PE- or high-KCl-induced contractions. However, both DHA and EPA generated more potent inhibitions against contractions induced by U46619 than those by PGF(2α). In contrast, LA did not show significant inhibitory effects against any contractions, including those induced by U46619. The present findings suggest that DHA and EPA elicit more selective inhibition against blood vessel contractions that are mediated through stimulation of prostanoid receptors than those through α-adrenoceptor stimulation or membrane depolarization. Although DHA and EPA have similar inhibitory potencies against prostanoid receptor-mediated contractions, they had a more potent inhibition against TXA(2) receptor (TP receptor)-mediated contractions than against PGF(2α) receptor (FP receptor)-mediated responses. Selective inhibition by either DHA or EPA of prostanoid receptor-mediated blood vessel contractions may partly underlie the mechanisms by which these ω-3 polyunsaturated fatty acids exert their circulatory-protective effects.

Citing Articles

Inhibitory mechanisms of docosahexaenoic acid on carbachol-, angiotensin II-, and bradykinin-induced contractions in guinea pig gastric fundus smooth muscle.

Xu K, Shimizu M, Yamashita T, Fujiwara M, Oikawa S, Ou G Sci Rep. 2024; 14(1):11720.

PMID: 38778154 PMC: 11111694. DOI: 10.1038/s41598-024-62578-y.

Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?.

Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P Int J Mol Sci. 2023; 24(11).

PMID: 37298468 PMC: 10253816. DOI: 10.3390/ijms24119520.

Omega-3 polyunsaturated fatty acid-induced vasodilation in mouse aorta and mesenteric arteries is not mediated by ATP-sensitive potassium channels.

Bercea C, Limbu R, Behnam K, Ng K, Aziz Q, Tinker A Front Physiol. 2023; 13:1033216.

PMID: 36589427 PMC: 9797959. DOI: 10.3389/fphys.2022.1033216.

Eicosapentaenoic acid (EPA)-induced inhibitory effects on porcine coronary and cerebral arteries involve inhibition of prostanoid TP receptors.

Yoshioka K, Obara K, Oikawa S, Uemura K, Yamaguchi A, Fujisawa K Sci Rep. 2022; 12(1):12829.

PMID: 35896794 PMC: 9329469. DOI: 10.1038/s41598-022-16917-6.

Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor-dependent contractions of guinea pig gastric fundus smooth muscle.

Xu K, Shimizu M, Murai C, Fujisawa M, Ito D, Saitoh N Pharmacol Res Perspect. 2022; 10(3):e00952.

PMID: 35466586 PMC: 9035583. DOI: 10.1002/prp2.952.

References

Engler M . Vascular relaxation to omega-3 fatty acids: comparison to sodium nitroprusside, nitroglycerin, papaverine, and D600. Cardiovasc Drugs Ther. 1992; 6(6):605-10. DOI: 10.1007/BF00052562. View

Engler M, Engler M, Ursell P . Vasorelaxant properties of n-3 polyunsaturated fatty acids in aortas from spontaneously hypertensive and normotensive rats. J Cardiovasc Risk. 1994; 1(1):75-80. View

Geleijnse J, Giltay E, Grobbee D, Donders A, Kok F . Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002; 20(8):1493-9. DOI: 10.1097/00004872-200208000-00010. View

Asano M, Nakajima T, Iwasawa K, Hazama H, Omata M, Soma M . Inhibitory effects of omega-3 polyunsaturated fatty acids on receptor-mediated non-selective cation currents in rat A7r5 vascular smooth muscle cells. Br J Pharmacol. 1997; 120(7):1367-75. PMC: 1564604. DOI: 10.1038/sj.bjp.0701047. View

Raz A, Isakson P, Minkes M, NEEDLEMAN P . Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator. J Biol Chem. 1977; 252(3):1123-6. View

Engler M, Engler M . Influence of aging on the relaxant responses to omega-3 fatty acids in Fischer 344 rat aorta. Gerontology. 1996; 42(1):25-35. DOI: 10.1159/000213767. View

Bunting S, Gryglewski R, Moncada S, Vane J . Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976; 12(6):897-913. DOI: 10.1016/0090-6980(76)90125-8. View

McLennan P, Howe P, Abeywardena M, Muggli R, Raederstorff D, Mano M . The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol. 1996; 300(1-2):83-9. DOI: 10.1016/0014-2999(95)00861-6. View

Appel L, Miller 3rd E, Seidler A, Whelton P . Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993; 153(12):1429-38. View

10.

Hui R, St-Louis J, Falardeau P . Antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids independent of the prostaglandin system. Am J Hypertens. 1989; 2(8):610-7. DOI: 10.1093/ajh/2.8.610. View

11.

Narumiya S, Sugimoto Y, Ushikubi F . Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999; 79(4):1193-226. DOI: 10.1152/physrev.1999.79.4.1193. View

12.

Chen G, Yamamoto Y, Miwa K, Suzuki H . Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am J Physiol. 1991; 260(6 Pt 2):H1888-92. DOI: 10.1152/ajpheart.1991.260.6.H1888. View

13.

Hoshi T, Wissuwa B, Tian Y, Tajima N, Xu R, Bauer M . Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca²⁺-dependent K⁺ channels. Proc Natl Acad Sci U S A. 2013; 110(12):4816-21. PMC: 3607063. DOI: 10.1073/pnas.1221997110. View

14.

Moreno J, Mitjavila M . The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review). J Nutr Biochem. 2003; 14(4):182-95. DOI: 10.1016/s0955-2863(02)00294-2. View

15.

Engler M . Effects of omega-3, omega-6 and omega-9 fatty acids on vascular smooth muscle tone. Eur J Pharmacol. 1992; 215(2-3):325-8. DOI: 10.1016/0014-2999(92)90050-e. View

16.

Wang R, Chai Q, Lu T, Lee H . Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity. Cardiovasc Res. 2010; 90(2):344-52. PMC: 3078798. DOI: 10.1093/cvr/cvq411. View

17.

Lawson D, Mehta J, Saldeen K, Mehta P, Saldeen T . Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids. 1991; 4(4):217-23. View

18.

He K, Song Y, Daviglus M, Liu K, Van Horn L, Dyer A . Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke. 2004; 35(7):1538-42. DOI: 10.1161/01.STR.0000130856.31468.47. View

19.

Swann P, Venton D, Le Breton G . Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett. 1989; 243(2):244-6. DOI: 10.1016/0014-5793(89)80137-1. View

20.

Holub D, Holub B . Omega-3 fatty acids from fish oils and cardiovascular disease. Mol Cell Biochem. 2016; 263(1):217-25. DOI: 10.1023/B:MCBI.0000041863.11248.8d. View